除細動器の世界市場：植込み型除細動器（T-ICD、S-ICD）、体外式除細動器（手動式、AED、WCD）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 18
1.3 STUDY SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 REGIONAL SCOPE 19
1.3.3 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY AND PRICING 20
1.5 LIMITATIONS 20
1.6 MARKET STAKEHOLDERS 20

2 RESEARCH METHODOLOGY 21
2.1 RESEARCH DATA 21
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY DATA 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Key industry insights 24
2.1.2.3 Breakdown of Primaries 24
2.2 FACTOR ANALYSIS 25
2.2.1 INTRODUCTION 25
2.2.2 DEMAND-SIDE ANALYSIS 25
2.2.2.1 Rapid growth of aging population 25
2.2.2.2 Burden of cardiovascular disease (CVD) 27
2.2.2.3 Healthcare expenditure patterns 29
2.2.2.4 Number of Hospitals 30
2.2.2.5 Increasing number of implant procedures 31
2.2.3 SUPPLY-SIDE ANALYSIS 32
2.2.3.1 Parent market analysis: Cardiac rhythm management (CRM) devices market 32
2.2.3.2 Key strategy adopted by market players 33
2.3 MARKET SIZE ESTIMATION 34
2.3.1 BOTTOM-UP APPROACH 34
2.3.2 TOP-DOWN APPROACH 35
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 36
2.5 RESEARCH ASSUMPTIONS AND LIMITATIONS 37
2.5.1 ASSUMPTIONS 37
2.5.2 LIMITATIONS 37

3 EXECUTIVE SUMMARY 38
3.1 INTRODUCTION 38
3.2 CURRENT SCENARIO 39
3.3 FUTURE OUTLOOK 39

4 PREMIUM INSIGHTS 44
4.1 ATTRACTIVE OPPORTUNITIES IN THE DEFIBRILLATORS MARKET 44
4.2 DEFIBRILLATORS MARKET – PRODUCT SEGMENTS 45
4.3 DEFIBRILLATORS MARKET: BY COUNTRY, 2014 45
4.4 DEFIBRILLATORS MARKET: T-ICDs MARKET (2019) 46
4.5 DEFIBRILLATORS MARKET: DEVELOPED VS. DEVELOPING NATIONS 47
4.6 DEFIBRILLATORS MARKET IN THE ASIA-PACIFIC REGION 48

5 MARKET OVERVIEW 49
5.1 INTRODUCTION 50
5.2 MARKET SEGMENTATION 50
5.2.1 DEFIBRILLATORS MARKET, BY PRODUCT 50
5.2.2 DEFIBRILLATORS MARKET, BY END USER 51
5.3 MARKET EVOLUTION 51
5.4 MARKET DYNAMICS 53
5.4.1 DRIVERS 54
5.4.1.1 Technological advancements 54
5.4.1.2 Rapid growth in aging population with higher risk of target diseases 54
5.4.1.3 Increasing burden of cardiovascular diseases across the globe 54
5.4.1.4 Growing focus of public and private organizations and key market players towards public access defibrillators 55
5.4.1.5 Increasing number of defibrillator training programs and campaigns across geographies 55
5.4.2 RESTRAINTS 56
5.4.2.1 Lack of awareness about Sudden Cardiac Arrest (SCA) across the globe 56
5.4.2.2 Unfavorable healthcare reforms in the U.S. 56
5.4.3 OPPORTUNITIES 57
5.4.3.1 Emerging markets offer numerous opportunities 57
5.4.3.2 Home-use defibrillators 57
5.4.3.3 Development of subcutaneous implantable cardioverter defibrillator (S-ICD) 58
5.4.4 CHALLENGES 58
5.4.4.1 Increasing pricing pressure on market players 58
5.4.4.2 Issues related to the use of implantable and automated external defibrillators 59
5.4.4.3 Frequent product recalls 59
 
5.5 WINNING IMPERATIVES 60
5.5.1 GEOGRAPHIC EXPANSION IN EMERGING MARKETS 60

6 INDUSTRY TRENDS 61
6.1 INTRODUCTION 61
6.2 VALUE CHAIN ANALYSIS 61
6.3 SUPPLY CHAIN ANALYSIS 62
6.3.1 KEY STAKEHOLDERS 63
6.3.2 KEY INFLUENCERS 64
6.4 INDUSTRY TRENDS 65
6.4.1 DEVELOPMENT OF INNOVATIVE, EASY-TO-USE PRODUCTS WITH INCREASED LONGEVITY 65
6.4.2 MERGERS AND ACQUISITIONS TO STRENGTHEN COMPANIES’ MARKET POSITIONS 65
6.4.3 RISING DEMAND FOR AUTOMATED EXTERNAL DEFIBRILLATORS IN THE PUBLIC ACCESS AND PRE-HOSPITAL MARKET 66
6.5 PORTER’S FIVE FORCES ANALYSIS 67
6.5.1 THREAT OF NEW ENTRANTS 67
6.5.2 THREAT OF SUBSTITUTES 68
6.5.3 BARGAINING POWER OF SUPPLIERS 68
6.5.4 BARGAINING POWER OF BUYERS 68
6.5.5 INTENSITY OF COMPETITIVE RIVALRY 69
6.6 STRATEGIC BENCHMARKING 69
6.6.1 NEW PRODUCT LAUNCH 69
6.6.2 INCREASING FOCUS OF KEY MARKET PLAYERS ON CONTRACTS AND TENDERS 70

7 GLOBAL DEFIBRILLATORS MARKET, BY PRODUCT 72
7.1 INTRODUCTION 73
7.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET 75
7.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (T-ICD) 76
7.2.1.1 Biventricular ICDs/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) 78
7.2.1.2 Dual-chamber ICDs 79
7.2.1.3 Single-chamber ICDs 80
7.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (S-ICDs) 81
7.3 EXTERNAL DEFIBRILLATORS 83
7.3.1 MANUAL EXTERNAL DEFIBRILLATORS 85
7.3.2 AUTOMATED EXTERNAL DEFIBRILLATORS (AEDs) 86
7.3.2.1 Semi-automated external defibrillators 87
7.3.2.2 Fully-automated external defibrillators 88
7.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS (WCDs) 90
 
8 GLOBAL DEFIBRILLATORS MARKET, BY END USER 91
8.1 INTRODUCTION 92
8.2 HOSPITALS 93
8.3 PREHOSPITALS 95
8.4 PUBLIC ACCESS MARKETS 96
8.5 ALTERNATE CARE MARKETS 99
8.6 HOMES 100

9 GLOBAL DEFIBRILLATORS MARKET, BY REGION 101
9.1 INTRODUCTION 102
9.2 NORTH AMERICA 103
9.2.1 U.S. 107
9.2.2 CANADA 110
9.3 EUROPE 112
9.3.1 GERMANY 116
9.3.2 U.K. 118
9.3.3 FRANCE 120
9.3.4 REST OF EUROPE 122
9.4 ASIA-PACIFIC 124
9.4.1 JAPAN 128
9.4.2 CHINA 130
9.4.3 INDIA 133
9.4.4 REST OF ASIA-PACIFIC 135
9.5 REST OF THE WORLD (RoW) 137
9.5.1 LATIN AMERICA 140
9.5.2 MIDDLE EAST 140
9.5.3 AFRICA 141

10 COMPETITIVE LANDSCAPE 143
10.1 OVERVIEW 143
10.2 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2013 144
10.2.1 KEY PLAYERS IN THE IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET 144
10.2.2 KEY PLAYERS IN THE EXTERNAL DEFIBRILLATORS MARKET 145
10.3 COMPETITIVE SITUATION AND TRENDS 146
10.3.1 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS 147
10.3.2 AGREEMENTS, PARTNERSHIPS, CONTRACTS, AND COLLABORATIONS 148
10.3.3 MERGERS AND ACQUISITIONS 150
10.3.4 GEOGRAPHICAL EXPANSIONS 151
10.3.5 OTHER DEVELOPMENTS 152
 
11 COMPANY PROFILES 153
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 INTRODUCTION 153
11.2 MEDTRONIC, INC. 154
11.3 ST. JUDE MEDICAL, INC. 157
11.4 BOSTON SCIENTIFIC CORPORATION 160
11.5 BIOTRONIK SE & CO.KG 163
11.6 SORIN GROUP 165
11.7 PHILIPS HEALTHCARE (A DIVISION OF KONINKLIJKE PHILIPS N.V.) 168
11.8 ZOLL MEDICAL CORPORATION (A SUBSIDIARY OF ASAHI KASEI CORPORATION) 171
11.9 PHYSIO-CONTROL, INC. 174
11.10 CARDIAC SCIENCE CORPORATION (A SUBSIDIARY OF OPTO CIRCUITS INDIA LIMITED) 176
11.11 NIHON KOHDEN CORPORATION 178
11.12 HEARTSINE TECHNOLOGIES, INC. 180
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

12 APPENDIX 182
12.1 INSIGHTS OF INDUSTRY EXPERTS 182
12.2 DISCUSSION GUIDE 183
12.3 COMPANY DEVELOPMENTS 189
12.3.1 MEDTRONIC, INC. 189
12.3.2 ST. JUDE MEDICAL, INC. 189
12.3.3 BOSTON SCIENTIFIC CORPORATION 190
12.3.4 BIOTRONIK SE & CO. KG 190
12.3.5 SORIN GROUP 191
12.3.6 KONINKLIJKE PHILIPS N.V. 191
12.3.7 ZOLL MEDICAL CORPORATION 192
12.3.8 CARDIAC SCIENCE CORPORATION 192
12.3.9 PHYSIO-CONTROL, INC. 193
12.3.10 NIHON KOHDEN CORPORATION 193
12.3.11 HEARTSINE TECHNOLOGIES, INC. 194
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 195
12.5 AVAILABLE CUSTOMIZATIONS 196
12.6 RELATED REPORTS 196